DEXCOM INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Dexcom Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Dexcom Inc Return On Equity for the quarter ending June 30, 2024 was 29.6 %, a 71.5% increase year-over-year.
  • Dexcom Inc annual Return On Equity for 2023 was 25 %, a 53.8% increase from 2022.
  • Dexcom Inc annual Return On Equity for 2022 was 16.2 %, a 51.3% increase from 2021.
  • Dexcom Inc annual Return On Equity for 2021 was 10.7 %, a 72.6% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 25 +8.74 +53.8% Jan 1, 2023 Dec 31, 2023
2022 16.2 +5.51 +51.3% Jan 1, 2022 Dec 31, 2022
2021 10.7 -28.4 -72.6% Jan 1, 2021 Dec 31, 2021
2020 39.2 +25.7 +191% Jan 1, 2020 Dec 31, 2020
2019 13.5 +37.3 Jan 1, 2019 Dec 31, 2019
2018 -23.9 -9.88 -70.6% Jan 1, 2018 Dec 31, 2018
2017 -14 +11.7 +45.4% Jan 1, 2017 Dec 31, 2017
2016 -25.7 +5.75 +18.3% Jan 1, 2016 Dec 31, 2016
2015 -31.4 -11.3 -55.8% Jan 1, 2015 Dec 31, 2015
2014 -20.1 +19 +48.5% Jan 1, 2014 Dec 31, 2014
2013 -39.1 +23.5 +37.5% Jan 1, 2013 Dec 31, 2013
2012 -62.6 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.